Literature DB >> 1711959

The management of diabetes mellitus in older individuals.

J E Morley1, H M Perry.   

Abstract

Nearly 50% of individuals with type II diabetes mellitus are over the age of 65 years. There are numerous reasons to maintain blood glucose levels below 11.1 nmol/L (200 mg/dl) in older persons, and there are a number of changes often seen with advancing age that persons, and there are a number of changes often seen with advancing age that may interfere with the management of diabetes mellitus, e.g. hypodipsia, anorexia, visual disturbance, altered renal and hepatic function, depression, impaired basoreceptor response and multiple medications. Hyperglycaemia appears to produce cognitive impairment which may lead to poor compliance. It is often difficult to manipulate diet in older people, and in fact dietary changes can lead to severe protein energy malnutrition. High maximum voluntary oxygen intake has been correlated with increased glucose disposal, but there is little evidence that physical exercise can improve diabetic control in the elderly. Oral sulphonylurea hypoglycaemic agents are extremely useful in the treatment of diabetes in these patients, but it should be remembered that they are more liable to develop hypoglycaemia than are younger diabetics. The role of metformin in the management of older diabetic patients is poorly studied. Many older persons can cope well with insulin therapy, but those with visual disturbances often make errors when drawing up insulin and require special attention. Combination therapy of insulin with oral hypoglycaemic agents is not recommended in this group of patients, and serum fructosamine is preferred to glycated haemoglobin to monitor control. Successful management of elderly diabetic patients thus requires an interdisciplinary team approach.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711959     DOI: 10.2165/00003495-199141040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  126 in total

1.  Effects of age on complications in adult onset diabetes.

Authors:  B D Naliboff; M Rosenthal
Journal:  J Am Geriatr Soc       Date:  1989-09       Impact factor: 5.562

2.  Mortality in a cohort of diabetic patients. Causes and relative risks.

Authors:  N R Waugh; J H Dallas; R T Jung; R W Newton
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Modulation of memory processing by neuropeptide Y varies with brain injection site.

Authors:  J F Flood; M L Baker; E N Hernandez; J E Morley
Journal:  Brain Res       Date:  1989-11-27       Impact factor: 3.252

Review 5.  Role of metformin in treatment of diabetes mellitus.

Authors:  R Vigneri; I D Goldfine
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

Review 6.  Metformin: a review of its pharmacological properties and therapeutic use.

Authors:  L S Hermann
Journal:  Diabete Metab       Date:  1979-09

7.  Decreased cognitive function in aging non-insulin-dependent diabetic patients.

Authors:  L C Perlmuter; M K Hakami; C Hodgson-Harrington; J Ginsberg; J Katz; D E Singer; D M Nathan
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

8.  Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus.

Authors:  W A Pulsinelli; D E Levy; B Sigsbee; P Scherer; F Plum
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

Review 9.  Anorexia in the elderly.

Authors:  J E Morley; A J Silver
Journal:  Neurobiol Aging       Date:  1988 Jan-Feb       Impact factor: 4.673

10.  [The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].

Authors:  W Berger; F Caduff; M Pasquel; A Rump
Journal:  Schweiz Med Wochenschr       Date:  1986-02-01
View more
  8 in total

Review 1.  Adverse reactions as a cause of hospital admission in the aged.

Authors:  K Beard
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 2.  Clinical pharmacokinetics of metformin.

Authors:  A J Scheen
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

Review 3.  Oral antidiabetic agents. A guide to selection.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

4.  Food-intake dysregulation in type 2 diabetic Goto-Kakizaki rats: hypothesized role of dysfunctional brainstem thyrotropin-releasing hormone and impaired vagal output.

Authors:  K Zhao; Y Ao; R M Harper; V L W Go; H Yang
Journal:  Neuroscience       Date:  2013-05-20       Impact factor: 3.590

Review 5.  Problems and pitfalls of sulphonylurea therapy in older patients.

Authors:  D A Robertson; P D Home
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

Review 6.  Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.

Authors:  C J Dunn; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

Review 7.  Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.

Authors:  A Ilarde; M Tuck
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

Review 8.  Antihyperglycaemic agents. Drug interactions of clinical importance.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.